BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1372560)

  • 1. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
    Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
    Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
    Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
    Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
    Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ
    J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
    Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ
    J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of peptide binding by the HLA-A2.1 molecule.
    Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
    J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a naturally occurring HLA class I-restricted viral epitope.
    Falk K; Rötzschke O; Stevanović S; Gnau V; Sparbier K; Jung G; Rammensee HG; Walden P
    Immunology; 1994 Jul; 82(3):337-42. PubMed ID: 7525458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
    Martinon F; Gomard E; Hannoun C; Lévy JP
    Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides.
    Nijman HW; Houbiers JG; van der Burg SH; Vierboom MP; Kenemans P; Kast WM; Melief CJ
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):121-6. PubMed ID: 7506574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
    Utz U; Koenig S; Coligan JE; Biddison WE
    J Immunol; 1992 Jul; 149(1):214-21. PubMed ID: 1607654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
    J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.